| Literature DB >> 34121351 |
Maja Arena Jørgensen1, Karen Johanne Pallesen2, Lone Overby Fjorback2, Lise Juul2.
Abstract
Long-term stress can lead to long-term increased cortisol plasma levels, which increases the risk of numerous diseases. Dehydroepiandrosterone (DHEA) and its sulfated form dehydroepiandrosterone-sulfate (DHEAS), together DHEA(S), have shown to counteract some of the effects of cortisol and may be protective during stress. The program "Mindfulness-Based Stress Reduction" (MBSR) has shown to have positive effects on stress. The present study examined a possible effect of MBSR on DHEAS in plasma compared to a waiting list and a locally developed stress reduction program (LSR) in people with self-reported stress. The study was a three-armed randomized controlled trial conducted in a municipal health care center in Denmark. It included 71 participants with self-reported stress randomized to either MBSR (n = 24) or LSR (n = 23), or a waiting list (n = 24). Blood samples were collected at baseline and at 12 weeks follow-up to estimate effects of MBSR on DHEAS. The effect of MBSR on DHEAS was statistically significant compared to both the waiting list and LSR. We found a mean effect of 0.70 µmol/L (95% confidence interval [CI] = 0.18-1.22) higher DHEAS in the MBSR group compared with the waiting list group and a mean effect of 0.54 µmol/L (95% CI = 0.04-1.05) higher DHEAS in the MBSR group compared with the LSR group. Findings indicate an effect on DHEAS of the MBSR program compared to a waiting list and LSR program in people with self-reported stress. However, we consider our findings hypothesis-generating and validation by future studies is essential.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34121351 PMCID: PMC8604255 DOI: 10.1111/cts.13100
Source DB: PubMed Journal: Clin Transl Sci ISSN: 1752-8054 Impact factor: 4.689
Characteristics of 71 participants included in a three‐armed pilot RCT among individuals seeking help due to stress in a Danish municipal health care center, 2018 from Juul et al.
| MBSR ( | LSR ( | Waiting list ( | |
|---|---|---|---|
| Gender, female (%) | 11 (46) | 16 (70) | 15 (63) |
| Age, median (q1, q3) | 46 (36, 51) | 41 (29, 49) | 45 (41, 52) |
| Education (%) | |||
| ≤11 years | 2 (8) | 1 (4) | 0 |
| >11 to <16 years | 6 (25) | 10 (43) | 10 (42) |
| ≥16 years | 16 (67) | 12 (52) | 14 (58) |
| Living alone (%) | 5 (21) | 4 (17) | 5 (21) |
| Living with parents (%) | 0 | 1 (4) | 0 |
| Living with a partner, no children (%) | 9 (38) | 7 (30) | 9 (38) |
| Living with a partner and children/adolescents (%) | 6 (25) | 3 (13) | 6 (25) |
| Living with children/adolescents, no partner (%) | 2 (8) | 4 (17) | 2 (8) |
| Living with other adults (%) | 2 (8) | 4 (17) | 2 (8) |
| Employment status | |||
| Employed (%) | 17 (71) (9 (53%) sick leave) | 15 (65) (8(53%) sick leave) | 16 (67) (13 (81%) sick leave) |
| Unemployed (%) | 3 (13) | 5 (22) | 5 (21) |
| Sick leave >3 months (%) | 2 (8) | 2 (9) | 2 (8) |
| Other | 2 (8) | 1 (4) | 1 (4) |
| Disease, present/earlier (%) | |||
| Asthma | 0/3 (13) | 3 (13)/1(4) | 1 (1)/1(1) |
| Diabetes | 0/0 | 1 (4)/0 | 0/0 |
| Hypertension | 3 (13)/1 (4) | 3 (13) /3 (13) | 3 (13)/3 (13) |
| Myocardial infarction | 0/0 | 0/0 | 0/0 |
| Angina pectoris | 0/2 (8) | 0/0 | 0/0 |
| Stroke | 0/0 | 0/0 | 0/0 |
| COLD | 0 /1 (4) | 1 (5)/0 | 0/0 |
| Osteoarthritis | 5 (21)/0 | 2 (9)/0 | 1 (4)/1 (4) |
| Rheumatoid arthritis | 2/(8)/0 | 1 (4)/0 | 0/1 (4) |
| Osteoporosis | 3 (13)/0 | 0/0 | 0/0 |
| Prolapse | 5 (21)/1 (4) | 1 (5)/2 (9) | 1 (4)/2 (8) |
| Cancer | 0 /1 (4) | 0/0 | 0/0 |
| Migraine | 7 (29)/2 (8) | 4 (17)/8 (35) | 6 (25)/4 (17) |
| Mental disorder ≤6 months | 5 (21)/3 (13) | 2 (9)/1 (4) | 2 (9) /1 (4) |
| Mental disorder >6 months | 4 (17)/1 (4) | 4 (18)/0 | 2 (8) /4 (17) |
| Self‐reported mental health | |||
| Perceived Stress Scale, mean (SD) | 24.6 (5.6) | 24.9 (5.6) | 26.6 (4.6) |
| Clinical measurements | |||
| Systolic blood pressure, mm Hg, mean (SD) | 127.1 (15.1) | 125.7 (18.9) | 123.4 (17.0) |
| Diastolic blood pressure, mm Hg, mean (SD) | 82.6 (9.9) | 80.7 (13.1) | 81.6 (11.6) |
| Weight, kg, median (q1, q3) | 79.0 (70.0, 92.0) | 75.0 (64.0, 92.0) | 68.5 (63.5, 84.0) |
| BMI, kg/m2 ≥25 (%) | 18 (75) | 14 (61) | 9 (39) |
| Waist circumference, cm, median (q1, q3) | 95.5 (90.5, 106.5) | 94.0 (87.0, 105.0) | 92.0 (80.5, 99.0) |
| DHEAS µmol/L mean (SD) | 3.17 (2.25) | 2.79 (1.38) | 3.45 (1.81) |
Abbreviations: RCT, randomized controlled trial; MBSR, Mindfulness‐Based Stress Reduction; LSR, locally developed stress reduction intervention; CI, confidence interval; q, quartile; BMI, body mass index; DHEAS, dehydroepiandrosterone‐sulfate.
FIGURE 1Flow chart showing loss to follow‐up in a three‐armed randomized controlled pilot study comparing effects of different stress interventions on the steroid hormone dehydroepiandosteron (DHEAS) levels in a real life setting in a municipal health care center in Denmark, 2018. LSR, local stress reduction program
Mean change and effect on DHEAS levels (µmol/L) from baseline to 12‐week follow‐up in the three groups
|
Baseline, mean (µmol/L) (SD) |
12‐week follow‐up, mean (µmol/L) (SD) | Mean change (95%CI) from baseline to 12‐week follow‐up |
Mean effect (µmol/L) of MBSR (95%CI), |
|---|---|---|---|
|
Waiting‐list ( 3.45 (1.81) |
Waiting‐list ( 3.04 (1.57) |
Waiting‐list ( −0.20 (−0.50 to 0.10) | REF |
|
MBSR ( 3.17 (2.25) |
MBSR ( 3.34 (1.70) |
MBSR ( 0.19 (−0.25 to 0.64) | 0.70 (0.18 to 1.22), 0.01 |
|
LSR ( 2.79 (1.38) |
LSR ( 2.64 (1.50) |
LSR ( −0.18 (−0.47 to 0.12) | REF |
|
MBSR ( 3.17 (2.25) |
MBSR ( 3.34 (1.70) |
MBSR ( 0.19 (−0.25 to 0.64) | 0.54 (0.04 to 1.05), 0.04 |
Includes participants with completion of outcome measures collected both at baseline and follow‐up.
Abbreviations: BMI, body mass index; DHEAS, dehydroepiandrosterone‐sulfate; MBSR, Mindfulness‐Based Stress Reduction; LSR, locally developed stress reduction program; CI, confidence interval.
Adjusted for gender, age, educational level, history of mental disease BMI, systolic‐ and diastolic blood pressure, DHEAS level and perceived stress score at baseline.
Sensitivity analysis: Effects in DHEAS levels (µmol/L) comparing the three groups when taken into account loss to follow‐up
|
Mean effect of MBSR (µmol/L) (95% CI), | |
|---|---|
| MBSR ( | 0.45 (0.05 to 0.84), 0.03 |
| MBSR ( | 0.37 (−0.02 to 0.76), 0.06 |
In this analysis, change in DHEAS levels from baseline to follow‐up was set to equal zero, for participants with missing follow‐up measurements.
Abbreviations: DHEASl; dehydroepiandrosterone‐sulfate; MBSR, Mindfulness Based Stress Reduction; LSR, locally developed stress reduction program, CI, confidence interval.
Adjusted for gender, age, educational level, history of mental disease BMI, systolic‐ and diastolic blood pressure, DHEAS level and perceived stress score at baseline.